CAS: 52193-54-1; Pyridin-1-Ium Trifluoromethanesulfonate

该化合物是一种该化合物是一种温和,高效的酸催化剂,特别是在需要受控酸性且无强性预产条件的反应中,这种物质低核糖分泌性和高热稳定性使其适合酯化,再配和弗里德尔-克利夫兰酸.三氟烷离子会增加极地有机溶剂溶解性,促进同质反应条件.与传统的强酸不同,它最大限度地减少分解或聚合等侧反应,提供更好的选择性.其固态可以确保易于处理和储存,使其在精细化学和制药应用中成为液体酸催化剂的实用替代物.

结构式图片

相似化合物

107263-95-6 390423-43-5 130433-68-0

欧盟法规

C&L通报

上下游产品

pyridine trifluorormethanesulfonic acid methyl-phenyl-thioether N-fluoropyridinium triflate3-oxo-3-phenylprop-1-en-2-yl acetate

合成工艺路线路线简述

    📜吡啶,氘代三氟甲磺酸 以 二氯甲烷作为反应溶剂,反应 0.75H,以95%的收率获得duetero-Pyridinium Triflate
    参考文献:[2+2+2] 甲硅烷氧基炔烃与 1,2-二嗪的环加成反应:从反应发现到抗糖酵解化学型的鉴定
    标题:[2+2+2] 甲硅烷氧基炔烃与 1,2-二嗪的环加成反应:从反应发现到抗糖酵解化学型的鉴定
    摘要:未发现环加成反应:在温和的反应条件下,标题反应产生了高效且具有优异非对映选择性的新型多环化合物.使用该反应合成的小分子文库产生了一种新的化学型,该化学型通过阻断 Cho-K1 细胞中的葡萄糖摄取来抑制糖酵解 Atp 的产生.Dmf= N,N-二甲基甲酰胺,Tf=三氟甲磺酰基,Tips=三异丙基甲硅烷基.
    Doi:10.1002/Anie.201305711

    海关参考信息

    专利信息


    专利号:US-2014235850-A1
    优先权日:2011-09-30
    标题:Synthesis of hmo core structures
    发明人:Kovács Imre; BAJZA ISTVÃ?N; HEDEROS MARKUS; DEKANY GYULA; DEMKÓ SÃ?NDOR; KHANZHIN NIKOLAY
    权利人:GLYCOM AS
    摘要:The invention relates to a method for making precursors of HMO core structures comprising a step of reacting an N-acetyllactosamine or lacto-N-biose derivative donor with a lactose or N-acetyllactosamine derivative acceptor, wherein the donor is an oxazoline donor.

    专利号:US-2023183283-A1
    优先权日:2016-10-14
    标题 :Novel glycoside compound and production method therefor
    发明人:OHGI TADAAKI; AOKI ERIKO; KINOSHITA TAKASHI; ITOH AKIHIRO; EMURA Chisato
    权利人:BONAC CORP
    摘要:The present invention aims to provide a method of producing, more efficiently at a high purity, a phosphoramidite preferable for the production (synthesis) of a nucleic acid. Using a coupling reaction of an ether represented by the following chemical formula (105), an enantiomer, tautomer or stereoisomer thereof, or a salt thereof, and a glycoside compound, phosphoramidite that enables efficient synthesis of nucleic acid can be obtained:wherein n is a positive integer, and R and R′ are the same or different and each is a hydrogen atom or a hydroxyl-protecting group.

    专利号:US-11667660-B2
    优先权日:2018-11-22
    标题 :Pyridinium salts as activators in the synthesis of stereodefined oligonucleotides
    发明人:HANSEN DENNIS JUL; FUNDER ERIK DAA
    权利人:ROCHE INNOVATION CT COPENHAGEN AS
    摘要:The present invention relates to a method for preparing stereodefined phosphorothioate oligonucleotides, especially locked stereodefined phosphorothioate oligonucleotides with a high yield, using pyridinium acidic salts as a coupling activator.

    专利号:US-2005215801-A1
    优先权日:2002-06-28
    标 题 :Process for preparation of optically active 1-substituted amino-2,3-epoxypropanes, intermediates for synthesis thereof and process for preparation of the intermediates
    发明人:KITAJIMA KUMI; NAGASHIMA NOBUO
    权利人:KITAJIMA KUMI; NAGASHIMA NOBUO
    摘要:The present invention provides an industrial process for effectively and advantageously preparing optically active 1-substituted amino-2,3-epoxypropanes useful as intermediates for preparing agricultural chemicals and medical products from optically active 1-substituted amino-2,3-propanediols used as raw materials. The present invention also provides useful intermediates. Specifically, an optically active 1-substituted amino-2,3-propanediol (1) is reacted with an orthoacid ester (2) or thionyl chloride (3) to produce a cyclic optically active compound (4), and then a compound (5) containing a halogen atom is prepared by reaction with a ring-opening reaction agent having an ability to introduce a halogen atom X. Finally, an optical active 1-substituted amino-2,3-epoxypropane is prepared by ring-closure reaction in the presence of a base.

    专利号:US-6846922-B1
    优先权日:1998-06-02
    标题 :Activators for oligonucleotide synthesis
    发明人:MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T
    权利人:ISIS PHARMACEUTICALS INC
    摘要:The present invention relates to improved methods for the preparation of nucleoside phosphoramidites and oligonucleotides. In one aspect, the methods of the invention are used to prepare phosphitylating reagents using pyridinium salts as activators. In a further aspect, the methods of the invention are used to prepare internucleoside linkages using activators which include at least one pyridinium salt and at least one substituted imidazole. In a further aspect, methods are provided preparation of internucleoside linkages between nucleosides having 2′-substituents using imidazolium or benzimidazolium salts as an activator. In a further aspect, methods are provided preparation of internucleoside linkages between nucleosides having bioreversible protecting group that confers enhanced chemical and biophysical properties, without exocyclic amine protection, using imidazolium or benzimidazolium salts as an activator.

    专利号:EP-3883941-A1
    优先权日:2018-11-22
    标 题:Pyridinium salts as activators in the synthesis of stereodefined oligonucleotides

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Dominik Jesariew, Et Al. Phase Transitions In Non-Centrosymmetric Pyridinium Trifluoromethanesulfonate Crystal: Vibrational Studies. Spectrochim Acta A Mol Biomol Spectrosc. 2015 Sep 5:148:203-14.

    合成参考文献


    参考文献:10.1038/s44160-023-00344-0
    摘要:Schneider T, Schwedtmann K, Fidelius J, Weigand JJ. Redox-neutral conversion of ubiquitous PV sources to a versatile PO2+ phosphorylation reagent. Nat. Synth. 2023 Jun 08;2(10):972–9. doi: 10.1038/s44160-023-00344-0.
    参考文献:10.1134/s0030400x2306019x
    摘要:Venidiktova OV, Gorelik AM, Koshkin AV, Barachevsky VA. Spectral-Kinetic Study of New Hybrid Photochromic Cumarinopyrans with Reversible Fluorescence Modulation. Opt. Spectrosc. 2023 Aug;131(8):777–80. doi: 10.1134/s0030400x2306019x.
    参考文献:10.1134/s1068162024050297
    摘要:Azev VN, Mustaeva LG, Gorbunova EY, Baidakova LK, Chulin AN, Maslov LN, Mukhomedzyanov AV, Molchanov МВ, Miroshnikov AI. Boc/Bzl Solid-Phase Synthesis of Deltorphin II and Its Analogs without the Utilization of Anhydrous Hydrogen Fluoride. Russ J Bioorg Chem. 2024 Oct;50(5):1701–9. doi: 10.1134/s1068162024050297.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知